Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patients.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Reassessing dissemination in space: The role of spinal cord lesion burden in early multiple sclerosis diagnosis.

Multiple sclerosis and related disorders·2026
Same author

Glial Plasticity and Dysfunction: Mechanistic Insights and Therapeutic Opportunities in Neurodegeneration.

Journal of neurochemistry·2026
Same author

Expert Opinion on Age-Related Sex Hormone Changes and Hypogonadism in People With Multiple Sclerosis: A Delphi Consensus Program.

Neurology. Clinical practice·2026
Same author

Paramagnetic Rim Lesions and Development of Clinical MS in Radiologically Isolated Syndrome.

JAMA neurology·2026

Related Experiment Video

Updated: Jul 7, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Vaccines for multiple sclerosis: progress to date.

Jorge Correale1, Mauricio Farez, Wendy Gilmore

  • 1Department of Neurology, Raúl Carrea Institute for Neurological Research, Buenos Aires, Argentina. jcorreale@fleni.org.ar

CNS Drugs
|February 19, 2008
PubMed
Summary
This summary is machine-generated.

Novel vaccine strategies, including T-cell vaccination (TCV) and DNA vaccination, show promise for treating multiple sclerosis (MS). These approaches aim to re-establish self-tolerance and suppress autoimmune responses in MS patients.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Related Experiment Videos

Last Updated: Jul 7, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Area of Science:

  • Neuroimmunology
  • Vaccinology
  • Autoimmune Diseases

Background:

  • Multiple sclerosis (MS) is a CNS inflammatory demyelinating disease with unknown etiology, likely involving autoimmune mechanisms.
  • Current disease-modifying agents for MS offer partial efficacy and limited impact on progressive phases.
  • There is a critical need for improved therapeutic strategies for multiple sclerosis.

Purpose of the Study:

  • To review novel vaccine strategies under investigation for multiple sclerosis treatment.
  • To explore the potential of T-cell vaccination (TCV), T-cell receptor (TCR) peptide vaccination, DNA vaccination, and altered peptide ligand (APL) vaccination.

Main Methods:

  • Review of current research on TCV, TCR peptide vaccination, DNA vaccination, and APL vaccination for MS.
  • Analysis of TCV's mechanism involving attenuated autoreactive T cells to induce regulatory networks.
  • Examination of DNA vaccination's potential to induce immune responses and re-establish self-tolerance.
  • Evaluation of APLs in modifying peptides to induce protective or reversing immune responses in EAE models.

Main Results:

  • TCV utilizes attenuated T cells to suppress pathogenic T cells, drawing parallels to infectious disease vaccination.
  • TCR peptide vaccination shows promise in animal models (EAE) but faces challenges due to T-cell receptor heterogeneity in MS patients.
  • DNA vaccination demonstrates potential for inducing immune responses and re-establishing self-tolerance in autoimmunity models.
  • APLs can modulate immune responses, but patient-specific heterogeneity requires further study for optimal therapeutic application.

Conclusions:

  • Vaccine strategies, including TCV, DNA vaccination, and APLs, represent promising avenues for MS treatment.
  • Further research is warranted to overcome challenges related to immune response heterogeneity in MS patients.
  • These novel vaccine approaches hold potential for treating MS and other autoimmune diseases.